Resources for students such as educational tools covering a variety of managed care topics and information on professional opportunities (internships, APPEs, fellowships and residencies) related to managed care pharmacy.

In this video, Jessica of Chadds Ford, Pennsylvania, shares her journey living with eosinophilic esophagitis (EOE), a chronic inflammatory condition that causes difficulty swallowing and food impactions. After years of symptoms that were initially treated as acid reflux, a biopsy finally confirmed her diagnosis.

AMCP applauds the House reintroduction of the Medicaid VBPs for Patients (MVP) Act (H.R. 7871) by Rep. Brett Guthrie (KY-02) alongside Rep. Jake Auchincloss (MA-04), Rep. Mariannette Miller-Meeks (IA-01), Rep. John Joyce (PA-13), Rep. Scott Peters (CA-50), and Rep. Don Davis (NC-01). This bipartisan legislation complements Senate bill S. 1637 and aims to improve patient access to novel therapies by enhancing the use of value-based purchasing arrangements in Medicaid.

At the start of each year, AMCP brings together its Board, Foundation Officers, Committee & Affiliate leaders, and corporate partners for the Winter Leadership Meeting. It’s where we align on priorities, strengthen relationships, and ensure the work ahead reflects AMCP’s mission and trends and topics in managed care pharmacy.

In February 2026, Senators Elizabeth Warren (D-MA) and Josh Hawley (R-MO) introduced the Break Up Big Medicine Act (S. 3822). The bipartisan legislation, referred to the Senate Judiciary Committee, aims to prohibit pharmacy benefit managers (PBMs), health insurers, and prescription drug or medical device wholesalers from being under common ownership with certain medical service providers or provider groups, including in-patient or outpatient pharmacies.

The Academy of Managed Care Pharmacy (AMCP) supports reforming the 340B Drug Pricing Program. While the program is intended to serve as an essential safety net that allows eligible healthcare entities to stretch federal resources and improve pharmaceutical access for vulnerable populations, stronger oversight, transparency, and accountability mechanisms are necessary to ensure it operates as Congress intended and delivers maximum benefit to patients and communities.

The AMCP Research Institute announced the launch of a new medication therapy management (MTM) health care improvement initiative designed to assess and manage modifiable risk factors for dementia in asymptomatic, middle-aged adults. The initiative is supported by a generous grant from Lilly and aims to address critical gaps in the identification and intervention of early dementia risk.